سوق التصوير التجريبي السريري - النمو والاتجاهات وتأثير COVID-19 والتنبؤات (2023-28)

Table of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Deliverables

   2. 1.2 Study Assumptions

   3. 1.3 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Market Drivers

      1. 4.2.1 Growth in The Pharmaceutical and Biotechnological Companies

      2. 4.2.2 Rise in Number of Contract Research Organization

      3. 4.2.3 Increase in R&D Spending

   3. 4.3 Market Restraints

      1. 4.3.1 High Implementation Barriers and Costs of Imaging Systems

   4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. MARKET SEGMENTATION

   1. 5.1 By Product and Service

      1. 5.1.1 Trial Design Consulting Services

      2. 5.1.2 Read Analysis Services

      3. 5.1.3 Operational Imaging Services

      4. 5.1.4 Imaging Software

   2. 5.2 By Modality

      1. 5.2.1 Magnetic Resonance Imaging

      2. 5.2.2 Computed Tomography

      3. 5.2.3 Ultrasound

      4. 5.2.4 Positron Emission Tomography

      5. 5.2.5 X-Ray

      6. 5.2.6 Echocardiography

      7. 5.2.7 Other Modalities

   3. 5.3 By End-User

      1. 5.3.1 Pharmaceutical Companies

      2. 5.3.2 Medical Device Manufacturers

      3. 5.3.3 Academic and Government Research Institutes

      4. 5.3.4 Other End-Users

   4. 5.4 Geography

      1. 5.4.1 North America

         1. 5.4.1.1 United States

         2. 5.4.1.2 Canada

         3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

         1. 5.4.2.1 Germany

         2. 5.4.2.2 United Kingdom

         3. 5.4.2.3 France

         4. 5.4.2.4 Italy

         5. 5.4.2.5 Spain

         6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

         1. 5.4.3.1 China

         2. 5.4.3.2 Japan

         3. 5.4.3.3 India

         4. 5.4.3.4 Australia

         5. 5.4.3.5 South Korea

         6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

         1. 5.4.4.1 GCC

         2. 5.4.4.2 South Africa

         3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

         1. 5.4.5.1 Brazil

         2. 5.4.5.2 Argentina

         3. 5.4.5.3 Rest of South America

6. 6. COMPETITIVE LANDSCAPE

   1. 6.1 Company Profiles

      1. 6.1.1 Bioclinica Inc.

      2. 6.1.2 Biomedical Systems Corporation

      3. 6.1.3 Biotelemetry Inc.

      4. 6.1.4 Cardiovascular Imaging Technologies LLC

      5. 6.1.5 Icon PLC

      6. 6.1.6 Intrinsic Imaging LLC

      7. 6.1.7 Ixico PLC

      8. 6.1.8 Parexel International Corporation

      9. 6.1.9 Radiant Sage LLC

      10. 6.1.10 Worldcare Clinical LLC

   *List Not Exhaustive

7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS